Glucose-dependent insulinotropic polypeptide: difference between revisions
Diff·revision 9 → 10·03:45, 15 Oct 2024
Difference between revision 9 and revision 10 of Glucose-dependent insulinotropic polypeptide. 2 lines changed; the page grew by 266 bytes.
| Revision 9 — 08:10, 26 Sep 2024 BetaCellBoyd (talk) expand §Biosynthesis and secretion 5,034 bytes ±0 | Revision 10 — 03:45, 15 Oct 2024 CiteBot (talk) bot: normalise citation format 5,300 bytes +266 | ||
|---|---|---|---|
| 1 | {{Infobox concept | 1 | {{Infobox concept |
| 2 | | name = Glucose-dependent insulinotropic polypeptide | 2 | | name = Glucose-dependent insulinotropic polypeptide |
| + | 3 | | subtitle = Incretin hormone | |
| 3 | | image = peptide-chain.svg | 4 | | image = peptide-chain.svg |
| 4 | | caption = GIP is a 42-residue peptide processed from pro-GIP in the duodenum and proximal jejunum. | 5 | | caption = GIP is a 42-residue peptide processed from pro-GIP in the duodenum and proximal jejunum. |
| ⋮ | ⋮ | ||
| 11 | | Plasma half-life = 7 minutes | 12 | | Plasma half-life = 7 minutes |
| 12 | }} | 13 | }} |
| + | 14 | {{hatnote|Formerly known as glucose-dependent insulinotropic peptide (GIP). For the GLP-1 arm of the incretin axis, see [[Glucagon-like peptide-1]]. For the receptor it acts on, see [[GLP-1 receptor agonist]] for clinical context.}} | |
| 13 | 15 | ||
| 14 | '''Glucose-dependent insulinotropic polypeptide''' ('''GIP'''), also termed '''glucose-dependent insulinotropic peptide''', is a 42-residue [[peptide]] hormone secreted by enteroendocrine K cells of the duodenum and proximal jejunum in response to the ingestion of glucose, fat and amino acids. It is one of the two principal [[Incretin effect|incretin]] hormones, the other being [[Glucagon-like peptide-1]] (GLP-1).{{r|nauck2019}} | 16 | '''Glucose-dependent insulinotropic polypeptide''' ('''GIP'''), also termed '''glucose-dependent insulinotropic peptide''', is a 42-residue [[peptide]] hormone secreted by enteroendocrine K cells of the duodenum and proximal jejunum in response to the ingestion of glucose, fat and amino acids. It is one of the two principal [[Incretin effect|incretin]] hormones, the other being [[Glucagon-like peptide-1]] (GLP-1).{{r|nauck2019}} |